Ganfort®/Ganfort®PF (bimatolprost/timolol)

Digital Adherence Program

Program overview

This sponsored program aims to provide education and support to patients prescribed Ganfort/Ganfort PF eye drops for the treatment of glaucoma.

Patients will receive a series of 12 messages over 6 months aimed at improving their quality use of medicines, medication adherence and treatment outcomes.

When?

This program was launched in May 2021.

For which patients?

Messages will be delivered via the app or SMS to patients currently prescribed Ganfort eye drops. 

Click here to view a sample of the messages

Ganfort naive